Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by MICHAEL FRUMOVITZ and PAMELA THERESE SOLIMAN.
MICHAEL FRUMOVITZ
Connection Strength
4.688
PAMELA THERESE SOLIMAN
  1. Unverifiable accomplishments and publications on applications for gynecologic oncology fellowships. Obstet Gynecol. 2012 Mar; 119(3):504-8.
    View in: PubMed
    Score: 0.431
  2. Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers. Curr Oncol Rep. 2022 11; 24(11):1521-1529.
    View in: PubMed
    Score: 0.221
  3. Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges. Int J Gynecol Cancer. 2020 03; 30(3):352-357.
    View in: PubMed
    Score: 0.186
  4. Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study. Cancer. 2019 10 01; 125(19):3347-3353.
    View in: PubMed
    Score: 0.179
  5. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer. J Gynecol Oncol. 2018 Sep; 29(5):e68.
    View in: PubMed
    Score: 0.165
  6. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecol Oncol. 2017 08; 146(2):234-239.
    View in: PubMed
    Score: 0.155
  7. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol. 2017 04; 145(1):96-101.
    View in: PubMed
    Score: 0.152
  8. Role of cervical cytology in surveillance after radical trachelectomy for cervical cancer. Gynecol Oncol. 2016 08; 142(2):283-5.
    View in: PubMed
    Score: 0.145
  9. Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer. Int J Gynecol Cancer. 2015 Oct; 25(8):1437-44.
    View in: PubMed
    Score: 0.138
  10. Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol. 2014 Dec; 124(6):1098-1104.
    View in: PubMed
    Score: 0.130
  11. Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation. Gynecol Oncol Rep. 2014 Dec; 10:28-9.
    View in: PubMed
    Score: 0.130
  12. Clinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia. Gynecol Oncol. 2014 Dec; 135(3):451-4.
    View in: PubMed
    Score: 0.129
  13. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol. 2014 Sep; 134(3):546-51.
    View in: PubMed
    Score: 0.127
  14. A case for caution in the pursuit of the sentinel node in women with endometrial carcinoma. Gynecol Oncol. 2014 Feb; 132(2):275-9.
    View in: PubMed
    Score: 0.122
  15. Pelvic exenteration: impact of age on surgical and oncologic outcomes. Gynecol Oncol. 2014 Jan; 132(1):114-8.
    View in: PubMed
    Score: 0.121
  16. Successful incorporation of robotic surgery into gynecologic oncology fellowship training. Gynecol Oncol. 2013 Dec; 131(3):730-3.
    View in: PubMed
    Score: 0.120
  17. Analgesic and antiemetic requirements after minimally invasive surgery for early cervical cancer: a comparison between laparoscopy and robotic surgery. Ann Surg Oncol. 2013 Apr; 20(4):1355-9.
    View in: PubMed
    Score: 0.112
  18. "Triple injection" lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with cervical cancer. Gynecol Oncol. 2012 Dec; 127(3):467-71.
    View in: PubMed
    Score: 0.111
  19. The effect of body mass index on surgical outcomes and survival following pelvic exenteration. Gynecol Oncol. 2012 May; 125(2):336-42.
    View in: PubMed
    Score: 0.107
  20. Modified vertical rectus abdominis myocutaneous flap vaginal reconstruction: an analysis of surgical outcomes. Gynecol Oncol. 2012 Apr; 125(1):252-5.
    View in: PubMed
    Score: 0.106
  21. Radical hysterectomy: a comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology. Gynecol Oncol. 2011 Nov; 123(2):333-6.
    View in: PubMed
    Score: 0.104
  22. Primary malignant melanoma of the vagina. Obstet Gynecol. 2010 Dec; 116(6):1358-1365.
    View in: PubMed
    Score: 0.099
  23. Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol. 2010 Nov; 119(2):291-4.
    View in: PubMed
    Score: 0.097
  24. Radical hysterectomy in obese and morbidly obese women with cervical cancer. Obstet Gynecol. 2008 Oct; 112(4):899-905.
    View in: PubMed
    Score: 0.085
  25. Laparoscopy training in gynecologic oncology fellowship programs. Gynecol Oncol. 2008 Nov; 111(2):197-201.
    View in: PubMed
    Score: 0.085
  26. Fertility preservation in patients with early cervical cancer: radical trachelectomy. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S25-8.
    View in: PubMed
    Score: 0.083
  27. Laparoscopic and robotic techniques for radical hysterectomy in patients with early-stage cervical cancer. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S21-4.
    View in: PubMed
    Score: 0.083
  28. Comparing long-term sexual dysfunction across different uterine cancer treatment modalities. Brachytherapy. 2024 Jan-Feb; 23(1):1-9.
    View in: PubMed
    Score: 0.061
  29. Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. Clin Cancer Res. 2021 12 01; 27(23):6354-6365.
    View in: PubMed
    Score: 0.052
  30. An Integrated Approach to Selecting a Prepared Medical Decision-Maker. J Pain Symptom Manage. 2021 06; 61(6):1305-1310.
    View in: PubMed
    Score: 0.050
  31. Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center. J Oncol Pract. 2019 12; 15(12):e1092-e1097.
    View in: PubMed
    Score: 0.046
  32. Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy. Front Immunol. 2018; 9:2102.
    View in: PubMed
    Score: 0.042
  33. A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice. Gynecol Oncol. 2018 11; 151(2):374-380.
    View in: PubMed
    Score: 0.042
  34. Potential immunotherapy targets in recurrent cervical cancer. Gynecol Oncol. 2017 06; 145(3):462-468.
    View in: PubMed
    Score: 0.038
  35. Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard? J Minim Invasive Gynecol. 2016 Feb 01; 23(2):186-93.
    View in: PubMed
    Score: 0.035
  36. Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer. J Magn Reson Imaging. 2016 Feb; 43(2):316-24.
    View in: PubMed
    Score: 0.034
  37. Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer. Gynecol Oncol. 2015 Jan; 136(1):48-53.
    View in: PubMed
    Score: 0.033
  38. Minimally invasive surgery for endometrial cancer: does operative start time impact surgical and oncologic outcomes? Gynecol Oncol. 2014 Aug; 134(2):248-52.
    View in: PubMed
    Score: 0.032
  39. A comparison of extraperitoneal versus transperitoneal laparoscopic or robotic para-aortic lymphadenectomy for staging of endometrial carcinoma. Gynecol Oncol. 2014 Feb; 132(2):366-71.
    View in: PubMed
    Score: 0.031
  40. Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignancies. Gynecol Oncol. 2013 Jun; 129(3):580-5.
    View in: PubMed
    Score: 0.029
  41. Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Gynecol Oncol. 2013 Feb; 128(2):204-8.
    View in: PubMed
    Score: 0.028
  42. Risk factors for prolonged hospitalization after gynecologic laparoscopic surgery. Gynecol Oncol. 2012 Sep; 126(3):428-31.
    View in: PubMed
    Score: 0.027
  43. Impact of smoking on perioperative pulmonary and upper respiratory complications after laparoscopic gynecologic surgery. Gynecol Oncol. 2012 Jun; 125(3):556-60.
    View in: PubMed
    Score: 0.027
  44. Quality of laparoscopic radical hysterectomy in developing countries: a comparison of surgical and oncologic outcomes between a comprehensive cancer center in the United States and a cancer center in Colombia. Gynecol Oncol. 2012 May; 125(2):326-9.
    View in: PubMed
    Score: 0.027
  45. Impact of surgeon volume on patient safety in laparoscopic gynecologic surgery. Gynecol Oncol. 2012 Apr; 125(1):241-4.
    View in: PubMed
    Score: 0.027
  46. Comparison of single-port laparoscopy, standard laparoscopy, and robotic surgery in patients with endometrial cancer. Ann Surg Oncol. 2012 May; 19(5):1583-8.
    View in: PubMed
    Score: 0.026
  47. Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force. Gynecol Oncol. 2012 Feb; 124(2):180-4.
    View in: PubMed
    Score: 0.026
  48. Fertility sparing surgery for treatment of early-stage cervical cancer: open vs. robotic radical trachelectomy. Gynecol Oncol. 2012 Feb; 124(2):276-80.
    View in: PubMed
    Score: 0.026
  49. Rate of port-site metastasis is uncommon in patients undergoing robotic surgery for gynecological malignancies. Int J Gynecol Cancer. 2011 Jul; 21(5):936-40.
    View in: PubMed
    Score: 0.026
  50. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer. 2011 May 01; 117(9):1928-34.
    View in: PubMed
    Score: 0.025
  51. Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery. Obstet Gynecol. 2010 Oct; 116(4):956-961.
    View in: PubMed
    Score: 0.024
  52. Rate of vaginal cuff separation following laparoscopic or robotic hysterectomy. Gynecol Oncol. 2011 Jan; 120(1):47-51.
    View in: PubMed
    Score: 0.024
  53. Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. Gynecol Oncol. 2010 Dec; 119(3):422-5.
    View in: PubMed
    Score: 0.024
  54. Pelvic fractures after radiotherapy for cervical cancer: implications for survivors. Cancer. 2010 Feb 01; 116(3):625-30.
    View in: PubMed
    Score: 0.023
  55. Trends in laparoscopic and robotic surgery among gynecologic oncologists: A survey update. Gynecol Oncol. 2009 Mar; 112(3):501-5.
    View in: PubMed
    Score: 0.022
  56. A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer. J Minim Invasive Gynecol. 2008 Sep-Oct; 15(5):584-8.
    View in: PubMed
    Score: 0.021
  57. Are women ready for the HPV vaccine? Gynecol Oncol. 2006 Oct; 103(1):151-4.
    View in: PubMed
    Score: 0.018
  58. Electrothermal bipolar coagulation for pelvic exenterations. Gynecol Oncol. 2006 Sep; 102(3):534-6.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.